Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
Matteo Allegretti, Alessandra Fabi, Elena Giordani, Cristiana Ercolani, Paolo Romania, Cecilia Nisticò, Simona Gasparro, Vittoria Barberi, Maria Ciolina, Edoardo Pescarmona, Diana Giannarelli, Gennaro Ciliberto, Francesco Cognetti, Patrizio Giacomini
Topics & Concepts
Trastuzumab emtansineTrastuzumabBreast cancerBiologyOncologyCancerInternal medicineBiopsyLiquid biopsyAcquired resistanceBioinformaticsComputational biologyCancer researchMedicineHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchChronic Lymphocytic Leukemia Research